Bath & Body Works (BBWI) Stock Price, News & Analysis

Company Overview

Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.

Key Stats

• Today's Range: $29.81 to $31.30
• 50-Day Range: $25.43 to $41.04
• 52-Week Range: $24.96 to $52.99
• Volume: 5.69 million shs
• Average Volume: 4.79 million shs
• Market Capitalization: $6.69 billion
• P/E Ratio: 7.61
• Dividend Yield: 2.56%
• Price Target: $42.69
• Consensus Rating: Moderate Buy

Bath & Body Works Stock Analysis - MarketRank™

Bath & Body Works scored higher than 98% of companies evaluated by MarketBeat, and ranked 4th out of 214 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Bath & Body Works has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 14 buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Bath & Body Works has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 12.12%

Earnings Growth

Earnings for Bath & Body Works are expected to grow by 12.12% in the coming year, from $3.30 to $3.70 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Bath & Body Works is 7.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.76.

Price to Earnings Ratio vs. Sector

The P/E ratio of Bath & Body Works is 7.61, which means that it is trading at a less expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 22.61.

Price to Earnings Growth Ratio

Bath & Body Works has a PEG Ratio of 0.92. PEG Ratios below 1 indicate that a company could be undervalued.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.14% of the float of Bath & Body Works has been sold short.

Short Interest Ratio / Days to Cover

Bath & Body Works has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Bath & Body Works has recently increased by 16.08%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Bath & Body Works pays a meaningful dividend of 2.78%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Bath & Body Works does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Bath & Body Works is 21.98%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Bath & Body Works will have a dividend payout ratio of 21.62% next year. This indicates that Bath & Body Works will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 1.2 / 5
• Environmental Score: -2.97

Percentage of Shares Shorted

3.14% of the float of Bath & Body Works has been sold short.

Short Interest Ratio / Days to Cover

Bath & Body Works has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Bath & Body Works has recently increased by 16.08%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.13

News Sentiment

Bath & Body Works has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Retail/Wholesale companies.

News Coverage This Week

MarketBeat has tracked 23 news articles for Bath & Body Works this week, compared to 11 articles on an average week.

Search Interest

Only 6 people have searched for BBWI on MarketBeat in the last 30 days. This is a decrease of -14% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Bath & Body Works to their MarketBeat watchlist in the last 30 days. This is a decrease of -82% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Bath & Body Works insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.27% of the stock of Bath & Body Works is held by insiders.

Percentage Held by Institutions

95.14% of the stock of Bath & Body Works is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

BBWI Stock Analysis - Frequently Asked Questions

How have BBWI shares performed this year?

Bath & Body Works' stock was trading at $38.77 at the beginning of 2025. Since then, BBWI shares have decreased by 19.5% and is now trading at $31.21.
View the best growth stocks for 2025 here.

How were Bath & Body Works' earnings last quarter?

Bath & Body Works, Inc. (NYSE:BBWI) released its quarterly earnings data on Thursday, February, 27th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a negative trailing twelve-month return on equity of 44.03% and a net margin of 12.43%.
Read the conference call transcript.

Is Bath & Body Works doing a stock buyback?

Bath & Body Works' board initiated a stock buyback program on Thursday, February 27th 2025, which authorizes the company to buy back $500,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 6.4% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

Who are Bath & Body Works' major shareholders?

Top institutional shareholders of Bath & Body Works include Assenagon Asset Management S.A. (0.77%), Rhumbline Advisers (0.27%), Principal Financial Group Inc. (0.27%) and OLD National Bancorp IN (0.16%). Insiders that own company stock include Gina Boswell, Wendy C Arlin and Thomas E Mazurek.
View institutional ownership trends.

How do I buy shares of Bath & Body Works?

Shares of BBWI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Bath & Body Works own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bath & Body Works investors own include Meta Platforms (META), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Home Depot (HD), Advanced Micro Devices (AMD), Chevron (CVX) and Cisco Systems (CSCO).

Company Calendar

• Record date for 3/7 Dividend: 2/21/2025
• Ex-Dividend for 3/7 Dividend: 2/21/2025
• Last Earnings: 2/27/2025
• Dividend Payable: 3/07/2025
• Today: 4/28/2025
• Next Earnings (Estimated): 5/29/2025
• Fiscal Year End: 1/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Retail/Wholesale
• Industry: Retail stores, not elsewhere classified
• Sub-Industry: Retail
• Current Symbol: NYSE:BBWI
• CIK: 701985
• Web: www.lb.com
• Phone: (614) 415-7000
• Fax: 614-415-7080
• Employees: 56,900
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $42.69
• High Stock Price Target: $52.00
• Low Stock Price Target: $35.00
• Potential Upside/Downside: +39.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.78
• Research Coverage: 18 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $3.64
• Trailing P/E Ratio: 7.49
• Forward P/E Ratio: 9.31
• P/E Growth: 0.92
• Net Income: $878 million
• Net Margins: 12.43%
• Pretax Margin: 13.98%
• Return on Equity: -44.03%
• Return on Assets: 14.45%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.09
• Quick Ratio: 0.34

Sales & Book Value

• Annual Sales: $7.31 billion
• Price / Sales: 0.90
• Cash Flow: $3.58 per share
• Price / Cash Flow: 8.58
• Book Value: ($7.20) per share
• Price / Book: -4.27

Miscellaneous

• Outstanding Shares: 214,226,000
• Free Float: 215,997,000
• Market Cap: $6.58 billion
• Optionable: Optionable
• Beta: 1.69